Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Rapamune Oral Solution


Contraindicated
Reproductive toxicity in animals

Contraindicated
Rapamune Oral Solution :
Type TAU
Originator B
Agent Food & Drug Corporation
Distributor Food & Drug Corporation
Laboratory Pfizer
Manufacturer Unknown Manufacturer
Origin N/A
ATC L04AA10

Your comment will appear shortly after approval

Rapamune Oral Solution :

Revision Date : 21/05/2015


Effect Frequency
Abdominal pain Very Common
Acne Very Common
ALT increased Very Common
Alveolar proteinosis Rare
Amenorrhoea (amenorrhea) Very Common
Anaemia Very Common
Anaphylactic reactions Common
Anaphylactoid reactions Common
Anastomotic complication Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Common
Arthralgia (Pain joint) (Joint ache) Very Common
Ascites Common
AST increased Very Common
Bacterial infection Very Common
Blood creatinine increased Very Common
Blood lactate dehydrogenase increased Very Common
Clostridium difficile colitis Uncommon
Constipation Very Common
Cytomegalovirus infection Common
Deep vein thrombosis Common
Dermatitis exfoliative Uncommon
Diabetes mellitus Very Common
Diarrhoea (Diarrhea) Very Common
Epistaxis (Nasal bleeding) Common
Epstein-Barr virus infection Uncommon
Focal segmental glomerulosclerosis Uncommon
Fungal infection Very Common
Haemolytic uraemic syndrome (HUS) Common
Headache Very Common
Hepatic failure (Hepatic insufficiency) (Liver failure) Uncommon
Hepatic necrosis Not known
Hepatotoxicity (liver toxicity) Not known
Herpes simplex Very Common
Herpes zoster Common
Hypercholesterolaemia Very Common
Hyperglycaemia Very Common
Hyperlipidaemia Very Common
Hypersensitivity Common
Hypersensitivity vasculitis Rare
Hypertension Very Common
Hypertriglyceridaemia Very Common
Hypokalaemia Very Common
Hypophosphataemia Very Common
Impaired healing Very Common
Incisional hernia Not known
Interstitial pneumonitis Not known
Leucopenia (Leukopenia) Very Common
Liver function test abnormal Very Common
Lymphocele Very Common
Lymphoedema Uncommon
Lymphoma Uncommon
Menorrhagia Very Common
Menstrual disorder Very Common
Mycobacterial infection Uncommon
Nausea Very Common
Nephrotic syndrome Uncommon
Neutropenia Common
Oedema Very Common
Oedema peripheral Very Common
Organising pneumonia Not known
Osteonecrosis Common
Ovarian cyst Common
Pain Very Common
Pancreatitis Common
Pancytopenia Uncommon
Pericardial effusion Common
Pleural effusion Common
Pneumonia Very Common
Pneumonitis Common
Polyomavirus-associated nephropathy Not known
Post transplant lymphoproliferative disorder Not known
Posterior reversible leukoencephalopathy syndrome (PRES) Not known
Progressive multifocal leukoencephalopathy Not known
Proteinuria Very Common
Pulmonary embolism Common
Pulmonary fibrosis Not known
Pulmonary haemorrhage Uncommon
Pyelonephritis Common
Pyrexia Very Common
Sepsis (Systemic infection) (Sepsis state) Common
Skin carcinoma (Skin cancer) Common
Skin rash Very Common
Sperm analysis abnormal Not known
Stomatitis Common
Tachycardia Very Common
Thrombocytopenia (Thrombopenia) Very Common
Thrombotic thrombocytopenic purpura (TTP) Uncommon
Tuberculosis Uncommon
Urinary tract infection Very Common
Venous thrombosis Common
Viral infection Very Common
Wound dehiscence Not known

Different Units By MoH Code

Revision Date : 01/01/2018

Revision Date : 01/05/2018

Rapamune Oral Solution  MoH 2063254 :
Form Oral solution
Packaging Bottle
Package Size 60ml
Strength 1mg/ml
Stratum N/A
NSSF ✘
Quarantine ✘


Price Comparison

● Country: Abu Dhabi
● Package Size: 60ml Glass Bottle + 30 Syringes + Kit
● Public Price: 1266.15 AED ( 30,591,450.15 LBP )
● Pack size unit used: 60
● Cost/Unit: 21,1025 AED ( 507,381.00 LBP )
● Pharmacy Price: 1101.96 AED ( 26624455.56 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: New Zealand
● Package Size: 60 ml
● Exfactory Price: 449.99 NZD
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info